Susan G. Komen
@susangkomen.bsky.social
Breast cancer research
Breast cancer care & financial support
Breast health advocacy & public policy
Breast cancer care & financial support
Breast health advocacy & public policy
Breast cancer screening and early detection play an important role in your health. Screening tests can help find breast cancer at an early stage when the chances of survival are highest.
Learn more about cancer screening: https://bit.ly/48RfhN7
Learn more about cancer screening: https://bit.ly/48RfhN7
December 5, 2025 at 3:49 PM
Breast cancer screening and early detection play an important role in your health. Screening tests can help find breast cancer at an early stage when the chances of survival are highest.
Learn more about cancer screening: https://bit.ly/48RfhN7
Learn more about cancer screening: https://bit.ly/48RfhN7
The fight against breast cancer matters. That’s why we are committed to transparency and accountability in everything we do.
Read our latest Impact Report to learn how your support is moving us closer to a world without breast cancer. https://bit.ly/3YKB0kE
Read our latest Impact Report to learn how your support is moving us closer to a world without breast cancer. https://bit.ly/3YKB0kE
November 23, 2025 at 6:22 PM
The fight against breast cancer matters. That’s why we are committed to transparency and accountability in everything we do.
Read our latest Impact Report to learn how your support is moving us closer to a world without breast cancer. https://bit.ly/3YKB0kE
Read our latest Impact Report to learn how your support is moving us closer to a world without breast cancer. https://bit.ly/3YKB0kE
Breast cancer is emerging as a global health crisis, yet with support from Komen, a groundbreaking tool called the Breast Cancer Care Quality Index is providing countries a roadmap to improve breast cancer care & save lives, regardless of the resources they have.
Learn more: https://bit.ly/3X34dG8
Learn more: https://bit.ly/3X34dG8
November 18, 2025 at 6:10 PM
Breast cancer is emerging as a global health crisis, yet with support from Komen, a groundbreaking tool called the Breast Cancer Care Quality Index is providing countries a roadmap to improve breast cancer care & save lives, regardless of the resources they have.
Learn more: https://bit.ly/3X34dG8
Learn more: https://bit.ly/3X34dG8
Drumroll please! 🥁
We’re pleased to share the results of the 2026 Race for the Cure/MORE THAN PINK Walk T-shirt design poll.
And the winner is… design #3! We can’t wait to see you rocking this new shirt in 2026!
We’re pleased to share the results of the 2026 Race for the Cure/MORE THAN PINK Walk T-shirt design poll.
And the winner is… design #3! We can’t wait to see you rocking this new shirt in 2026!
November 11, 2025 at 4:11 PM
Drumroll please! 🥁
We’re pleased to share the results of the 2026 Race for the Cure/MORE THAN PINK Walk T-shirt design poll.
And the winner is… design #3! We can’t wait to see you rocking this new shirt in 2026!
We’re pleased to share the results of the 2026 Race for the Cure/MORE THAN PINK Walk T-shirt design poll.
And the winner is… design #3! We can’t wait to see you rocking this new shirt in 2026!
🌍🔬 At ESMO 2025, breast cancer news went off:
📍Chemo-free options for HER2+
📍Improved options in TNBC
📍Keeping cancer recurrence at bay
📍New options for metastatic ER+ BC
Read the highlights in our blog: https://bit.ly/4hHohat
📍Chemo-free options for HER2+
📍Improved options in TNBC
📍Keeping cancer recurrence at bay
📍New options for metastatic ER+ BC
Read the highlights in our blog: https://bit.ly/4hHohat
November 5, 2025 at 5:14 PM
🌍🔬 At ESMO 2025, breast cancer news went off:
📍Chemo-free options for HER2+
📍Improved options in TNBC
📍Keeping cancer recurrence at bay
📍New options for metastatic ER+ BC
Read the highlights in our blog: https://bit.ly/4hHohat
📍Chemo-free options for HER2+
📍Improved options in TNBC
📍Keeping cancer recurrence at bay
📍New options for metastatic ER+ BC
Read the highlights in our blog: https://bit.ly/4hHohat
Many new treatments for MBC today are under study in clinical trials. Patient navigator Miranda Zinn shares how she and her team of navigators in the Komen Patient Care Center support the MBC community by guiding them to the right clinical trials.
Learn more: https://bit.ly/4opdC72
Learn more: https://bit.ly/4opdC72
November 4, 2025 at 4:07 PM
Many new treatments for MBC today are under study in clinical trials. Patient navigator Miranda Zinn shares how she and her team of navigators in the Komen Patient Care Center support the MBC community by guiding them to the right clinical trials.
Learn more: https://bit.ly/4opdC72
Learn more: https://bit.ly/4opdC72
🌍🔬 Day 3 #ESMO25 highlights:
📍Antibody drug conjugates transforming 1st-line treatment in metastatic breast cancer
📍Improved survival and longer disease control in HER2+ and TNBC
@myesmo.bsky.social #breastcancer (1/4)
📍Antibody drug conjugates transforming 1st-line treatment in metastatic breast cancer
📍Improved survival and longer disease control in HER2+ and TNBC
@myesmo.bsky.social #breastcancer (1/4)
October 19, 2025 at 5:18 PM
🌍🔬 Day 3 #ESMO25 highlights:
📍Antibody drug conjugates transforming 1st-line treatment in metastatic breast cancer
📍Improved survival and longer disease control in HER2+ and TNBC
@myesmo.bsky.social #breastcancer (1/4)
📍Antibody drug conjugates transforming 1st-line treatment in metastatic breast cancer
📍Improved survival and longer disease control in HER2+ and TNBC
@myesmo.bsky.social #breastcancer (1/4)
🌍🔬 Day 2 #ESMO25 highlights:
📍Potential new post-CDK4/6 options for ER+/HER2- metastatic BC
📍ADCs in early HER2+ breast cancer
@myESMO #breastcancer (1/5)
📍Potential new post-CDK4/6 options for ER+/HER2- metastatic BC
📍ADCs in early HER2+ breast cancer
@myESMO #breastcancer (1/5)
October 19, 2025 at 1:04 AM
🌍🔬 Day 2 #ESMO25 highlights:
📍Potential new post-CDK4/6 options for ER+/HER2- metastatic BC
📍ADCs in early HER2+ breast cancer
@myESMO #breastcancer (1/5)
📍Potential new post-CDK4/6 options for ER+/HER2- metastatic BC
📍ADCs in early HER2+ breast cancer
@myESMO #breastcancer (1/5)
🌍🔬Day 1 #ESMO25 highlights:
📍Pregnancy safety in HR+ breast cancer
📍New practice-confirming insight into adjuvant CDK4/6 inhibitors for early HR+/HER2- breast cancer
@myESMO #breastcancer (1/4)
📍Pregnancy safety in HR+ breast cancer
📍New practice-confirming insight into adjuvant CDK4/6 inhibitors for early HR+/HER2- breast cancer
@myESMO #breastcancer (1/4)
October 17, 2025 at 7:38 PM
🌍🔬Day 1 #ESMO25 highlights:
📍Pregnancy safety in HR+ breast cancer
📍New practice-confirming insight into adjuvant CDK4/6 inhibitors for early HR+/HER2- breast cancer
@myESMO #breastcancer (1/4)
📍Pregnancy safety in HR+ breast cancer
📍New practice-confirming insight into adjuvant CDK4/6 inhibitors for early HR+/HER2- breast cancer
@myESMO #breastcancer (1/4)
It’s #ESMO25 week 🎗️
We’re tracking new data and key breast cancer studies at the European Society for Medical Oncology.
Follow us along here & on X for highlights and updates 💗
#BreastCancer #Oncology @myesmo.bsky.social
We’re tracking new data and key breast cancer studies at the European Society for Medical Oncology.
Follow us along here & on X for highlights and updates 💗
#BreastCancer #Oncology @myesmo.bsky.social
October 16, 2025 at 3:54 PM
It’s #ESMO25 week 🎗️
We’re tracking new data and key breast cancer studies at the European Society for Medical Oncology.
Follow us along here & on X for highlights and updates 💗
#BreastCancer #Oncology @myesmo.bsky.social
We’re tracking new data and key breast cancer studies at the European Society for Medical Oncology.
Follow us along here & on X for highlights and updates 💗
#BreastCancer #Oncology @myesmo.bsky.social
Today is National Donor Advised Fund Day! Consider using our quick and easy tool to make an immediate impact. Now more than ever, patients need your help.
Ending breast cancer needs all of us. Komen.org/DAF #DAFDay
Ending breast cancer needs all of us. Komen.org/DAF #DAFDay
October 9, 2025 at 2:01 PM
Today is National Donor Advised Fund Day! Consider using our quick and easy tool to make an immediate impact. Now more than ever, patients need your help.
Ending breast cancer needs all of us. Komen.org/DAF #DAFDay
Ending breast cancer needs all of us. Komen.org/DAF #DAFDay
For someone with breast cancer, genomic testing can be a personalized guide that helps themchoose a treatment path with the greatest benefit while possibly avoiding unnecessary detours.
Read more in the latest Know More blog: https://www.komen.org/blog/know-more-genomic-testing/
Read more in the latest Know More blog: https://www.komen.org/blog/know-more-genomic-testing/
October 6, 2025 at 7:11 PM
For someone with breast cancer, genomic testing can be a personalized guide that helps themchoose a treatment path with the greatest benefit while possibly avoiding unnecessary detours.
Read more in the latest Know More blog: https://www.komen.org/blog/know-more-genomic-testing/
Read more in the latest Know More blog: https://www.komen.org/blog/know-more-genomic-testing/
4 years ago, we released a first-of-its-kind report highlighting the breast cancer disparities bet. Black & white women. Today, we’re sharing an update: in 9 major U.S. metro areas where outcomes were the worst, more Black lives are being saved from breast cancer.
Read more: https://bit.ly/4ojeKsz
Read more: https://bit.ly/4ojeKsz
October 1, 2025 at 1:52 PM
4 years ago, we released a first-of-its-kind report highlighting the breast cancer disparities bet. Black & white women. Today, we’re sharing an update: in 9 major U.S. metro areas where outcomes were the worst, more Black lives are being saved from breast cancer.
Read more: https://bit.ly/4ojeKsz
Read more: https://bit.ly/4ojeKsz
October is National Breast Cancer Awareness Month and it's time to take action. From advocating for cancer research funding to supporting equitable care for all, your voice matters!
Visit komen.org to join the fight. Because ending breast cancer needs all of us.
Visit komen.org to join the fight. Because ending breast cancer needs all of us.
September 30, 2025 at 3:17 PM
October is National Breast Cancer Awareness Month and it's time to take action. From advocating for cancer research funding to supporting equitable care for all, your voice matters!
Visit komen.org to join the fight. Because ending breast cancer needs all of us.
Visit komen.org to join the fight. Because ending breast cancer needs all of us.
In case you missed it, check out the latest Breast Cancer Breakthroughs focused on how ctDNA is poised to revolutionize breast cancer care and read our blog to learn what it means for patients.
Watch the event & read the blog here: https://bit.ly/48C56MO
Watch the event & read the blog here: https://bit.ly/48C56MO
September 26, 2025 at 8:49 PM
In case you missed it, check out the latest Breast Cancer Breakthroughs focused on how ctDNA is poised to revolutionize breast cancer care and read our blog to learn what it means for patients.
Watch the event & read the blog here: https://bit.ly/48C56MO
Watch the event & read the blog here: https://bit.ly/48C56MO
Imlunestrant was just approved by the FDA to treat ER-positive, HER2-negative ESR1-mutated metastatic breast cancer. The approval was based on results from the phase 3 EMBER-3 clinical trial.
Read more on our What's New Page: https://bit.ly/3IW3ToM
Read more on our What's New Page: https://bit.ly/3IW3ToM
September 26, 2025 at 8:15 PM
Imlunestrant was just approved by the FDA to treat ER-positive, HER2-negative ESR1-mutated metastatic breast cancer. The approval was based on results from the phase 3 EMBER-3 clinical trial.
Read more on our What's New Page: https://bit.ly/3IW3ToM
Read more on our What's New Page: https://bit.ly/3IW3ToM
Breast cancer is rising in women under 50, but thanks to lifesaving clinical trials, there’s hope on the horizon.
In our next Spotlight on Clinical Trials, we explore four current clinical trials that focus specifically on the needs of young women. https://bit.ly/42LaOrS
In our next Spotlight on Clinical Trials, we explore four current clinical trials that focus specifically on the needs of young women. https://bit.ly/42LaOrS
September 25, 2025 at 7:14 PM
Breast cancer is rising in women under 50, but thanks to lifesaving clinical trials, there’s hope on the horizon.
In our next Spotlight on Clinical Trials, we explore four current clinical trials that focus specifically on the needs of young women. https://bit.ly/42LaOrS
In our next Spotlight on Clinical Trials, we explore four current clinical trials that focus specifically on the needs of young women. https://bit.ly/42LaOrS
NEW Breast Cancer Breakthroughs Sept. 25! Learn about how simple blood tests are being used to improve breast cancer care.
Info here: https://bit.ly/3X1yPW0
Info here: https://bit.ly/3X1yPW0
September 23, 2025 at 5:00 PM
NEW Breast Cancer Breakthroughs Sept. 25! Learn about how simple blood tests are being used to improve breast cancer care.
Info here: https://bit.ly/3X1yPW0
Info here: https://bit.ly/3X1yPW0
Discover how complementary therapies can support and empower breast cancer patients through treatment and recovery in our next Spotlight on Clinical Trials blog, where we explore three clinical trials testing their safety and effectiveness.
Learn more: https://bit.ly/3KacV26
Learn more: https://bit.ly/3KacV26
September 19, 2025 at 5:09 PM
Discover how complementary therapies can support and empower breast cancer patients through treatment and recovery in our next Spotlight on Clinical Trials blog, where we explore three clinical trials testing their safety and effectiveness.
Learn more: https://bit.ly/3KacV26
Learn more: https://bit.ly/3KacV26
Komen is joining #RallyMedRes to call on Congress to protect lifesaving research! Research funded by the NIH is at the cornerstone of new advances for #breastcancer care.
Take action and tell Congress to protect lifesaving research! #FundNIH #KomenAdvocacy
Take action and tell Congress to protect lifesaving research! #FundNIH #KomenAdvocacy
September 18, 2025 at 4:53 PM
Komen is joining #RallyMedRes to call on Congress to protect lifesaving research! Research funded by the NIH is at the cornerstone of new advances for #breastcancer care.
Take action and tell Congress to protect lifesaving research! #FundNIH #KomenAdvocacy
Take action and tell Congress to protect lifesaving research! #FundNIH #KomenAdvocacy
Nueva Vida is 1 of the 8 orgs in the ShareForCures alliance, and they are dedicated to supporting Latinos whose lives have been affected by cancer. Breast cancer affects people from all backgrounds, yet not every community is appropriately represented in research.
Learn more: https://bit.ly/3K8umQA
Learn more: https://bit.ly/3K8umQA
September 17, 2025 at 3:50 PM
Nueva Vida is 1 of the 8 orgs in the ShareForCures alliance, and they are dedicated to supporting Latinos whose lives have been affected by cancer. Breast cancer affects people from all backgrounds, yet not every community is appropriately represented in research.
Learn more: https://bit.ly/3K8umQA
Learn more: https://bit.ly/3K8umQA
Breast cancer is the leading cause of cancer death among Hispanic women in the U.S. We want to change that.
This Hispanic Heritage Month, we encourage the Hispanic & Latino communities to take charge of their breast health, get screened & learn their family health histories. https://bit.ly/44Oxsy1
This Hispanic Heritage Month, we encourage the Hispanic & Latino communities to take charge of their breast health, get screened & learn their family health histories. https://bit.ly/44Oxsy1
September 15, 2025 at 3:00 PM
Breast cancer is the leading cause of cancer death among Hispanic women in the U.S. We want to change that.
This Hispanic Heritage Month, we encourage the Hispanic & Latino communities to take charge of their breast health, get screened & learn their family health histories. https://bit.ly/44Oxsy1
This Hispanic Heritage Month, we encourage the Hispanic & Latino communities to take charge of their breast health, get screened & learn their family health histories. https://bit.ly/44Oxsy1
The stage of breast cancer when it is diagnosed is an important factor when determining prognosis.
Learn about what each of these stages means: https://bit.ly/46iiNhb
Learn about what each of these stages means: https://bit.ly/46iiNhb
September 12, 2025 at 7:56 PM
The stage of breast cancer when it is diagnosed is an important factor when determining prognosis.
Learn about what each of these stages means: https://bit.ly/46iiNhb
Learn about what each of these stages means: https://bit.ly/46iiNhb
We will never forget those we lost on Sept. 11, 2001.
September 11, 2025 at 2:09 PM
We will never forget those we lost on Sept. 11, 2001.
Learn more about HER2+ MBC and the latest breakthroughs in research, clinical trials and treatment strategies at our upcoming MBC Impact Series.
🗓️ September 17th at 1pm CT / 2pm ET
Register today: https://bit.ly/4m6PzaX
Thank you to our partner AstraZeneca for supporting the MBC Impact Series.
🗓️ September 17th at 1pm CT / 2pm ET
Register today: https://bit.ly/4m6PzaX
Thank you to our partner AstraZeneca for supporting the MBC Impact Series.
September 10, 2025 at 3:53 PM
Learn more about HER2+ MBC and the latest breakthroughs in research, clinical trials and treatment strategies at our upcoming MBC Impact Series.
🗓️ September 17th at 1pm CT / 2pm ET
Register today: https://bit.ly/4m6PzaX
Thank you to our partner AstraZeneca for supporting the MBC Impact Series.
🗓️ September 17th at 1pm CT / 2pm ET
Register today: https://bit.ly/4m6PzaX
Thank you to our partner AstraZeneca for supporting the MBC Impact Series.